BD Veritor Test Kit for Rapid Detection of SARS-CoV-2 and Flu A+B (CLIA-Waived Kit)

BD Veritor Test Kit for Rapid Detection of SARS-CoV-2 and Flu A+B (CLIA-Waived Kit)BD Veritor System for Rapid Detection of SARS CoV 2 & Flu A+B is a combination rapid antigen test designed to detect and differentiate between SARS CoV 2, Influenza A, and Influenza B from a single patient sample. When used with the BD Veritor Plus Analyzer, it provides fast, objective results to support accurate diagnosis and timely treatment decisions. Triple antigen detection: Simultaneously identifies SARS CoV 2, Influenza A, and Influenza B from

BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B is a combination rapid antigen test designed to detect and differentiate between SARS-CoV-2, Influenza A, and Influenza B from a single patient sample. When used with the BD Veritor™ Plus Analyzer, it provides fast, objective results to support accurate diagnosis and timely treatment decisions.

• Triple antigen detection: Simultaneously identifies SARS-CoV-2, Influenza A, and Influenza B from one nasal swab specimen.
• Rapid digital results: Delivers clear, objective analyzer-based results in approximately 15 minutes using the BD Veritor™ Plus System.
• Streamlined workflow: Simple, single-sample process reduces handling time and improves testing efficiency.
• Objective result interpretation: Analyzer eliminates subjective visual reading errors, ensuring consistent accuracy.
• Point-of-care ready: CLIA-waived for use in clinics, hospitals, urgent care centers, and physician offices.

Packaging: 30 Tests per Kit (Cat. No. 256088)

Recommended for rapid, point-of-care detection and differentiation of COVID-19 and Influenza A+B in symptomatic patients.